Evidence map›Paper›PMID 31519219›Full record

ArticleClinical epigenetics2019

Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy.

César N Cortés-Rubio, Gonzalo Salgado-Montes de Oca, Francisco J Prado-Galbarro, Margarita Matías-Florentino, Akio Murakami-Ogasawara, Leticia Kuri-Cervantes, Ana P Carranco-Arenas, Christopher E Ormsby, Ivette K Cortés-Rubio, Gustavo Reyes-Terán and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

César N Cortés-RubioCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Gonzalo Salgado-Montes de OcaCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Francisco J Prado-GalbarroNational Institute of Public Health, Mexico City, Mexico.
Margarita Matías-FlorentinoCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Akio Murakami-OgasawaraCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Leticia Kuri-CervantesDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ana P Carranco-ArenasCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Christopher E OrmsbyCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Ivette K Cortés-RubioAdolfo López Mateos Hospital, ISSSTE, Mexico City, Mexico.
Gustavo Reyes-TeránCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico.
Santiago Ávila-RíosCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Tlalpan 4502, 14080, Mexico City, Mexico. santiago.avila@cieni.org.mx.ORCID 0000-0003-3371-4248
Institute for Social Security and Services for State Workers · MXNational Institute of Genomic Medicine · MXUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersistence of latent, replication-competent provirus in CD4

results5'-LTR methylation was observed in all participants and behaved dynamically. The number of 5'-LTR variants found per sample ranged from 1 to 13, with median sequencing depth of 16270× (IQR 4107×-46760×). An overall significant 5'-LTR methylation increase was observed at month 42 compared to month 30 (median CpG Methylation Index: 74.7% vs. 0%, p = 0.025). This methylation increase was evident in a subset of participants (methylation increase group), while the rest maintained fairly high and constant methylation (constant methylation group). Persons in the methylation increase group were younger, had higher CD4

conclusionsOur study shows evidence that HIV 5'-LTR methylation in total CD4+ T cells is dynamic along time and that it can follow different temporal patterns that are associated with a combination of baseline and follow-up clinical characteristics. These observations may account for differences observed between previous contrasting studies.

Indexed as

DNA MethylationHIV Long Terminal RepeatAdultAge FactorsAntiretroviral Therapy, Highly ActiveCD4-Positive T-LymphocytesCross-Sectional StudiesFemaleHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedPrincipal Component Analysis5′-LTRCpGDNA methylationHIVLatencyLongitudinalNon-canonical methylationProviral loadResidual plasma viral load

Identifiers

PMID31519219
PMCPMC6743183
OpenAlexW2973159668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.